Cognition Therapeutics (CGTX) Other Non-Current Assets (2020 - 2023)

Cognition Therapeutics (CGTX) has 4 years of Other Non-Current Assets data on file, last reported at $1.8 million in Q3 2023.

• Quarterly Other Non-Current Assets rose 3.97% year-over-year to $1.8 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $1.8 million (up 3.97% YoY) and the FY2022 annual result came in at $1.7 million, changed N/A from the prior year.
• Other Non-Current Assets rose to $1.8 million in Q3 2023 per CGTX's latest filing, from $1.4 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $3.2 million in Q3 2021 and bottomed at $45000.0 in Q4 2020.
• The 4-year median for Other Non-Current Assets is $1.7 million (2022), against an average of $1.6 million.
• The widest annual swing landed in 2022, when Other Non-Current Assets sank 47.41%; it then climbed 29.5% in 2023.
• Tracing CGTX's Other Non-Current Assets over 4 years: stood at $45000.0 in 2020, then jumped by 7033.33% to $3.2 million in 2021, then tumbled by 46.04% to $1.7 million in 2022, then rose by 1.33% to $1.8 million in 2023.
• Per Business Quant, the three latest CGTX Other Non-Current Assets figures stand at $1.8 million (Q3 2023), $1.4 million (Q2 2023), and $1.8 million (Q1 2023).

Peer Comparison